
Chronic use of low-dose aspirin, defined as 300 mg/day or less, is associated with an increased risk of major gastrointestinal (GI) or cerebral bleeding, a recent review of administrative data found. Patients with diabetes also were found to have a high rate of bleeding, irrespective of aspirin use. Key Point:…
Read more »
ADVATE Now Available in India for the Treatment and Prophylaxis of Hemophilia A
Shire plc (LSE: SHP, NASDAQ: SHPG) announces today the launch of ADVATE (Octocog alfa – Recombinant Coagulation Factor VIII) in India for the treatment and prophylaxis of bleeding in patients with hemophilia A.
Read more »